@0f342e77 this is an interesting concept, but don't get your hopes up yet. It hasn't even passed safety trials. Which means effectiveness trials haven't even begun.

Also the article seems to only have one person as a source, who "...cofounded and is a consultant, board member, and equity holder" of the company trying to profit off this. 

 @eee3480d 

There are advancements in the research of MS in the UK which showed promise.

My hope is the acceleration of mRNA technology for use with COVID, will change the mindset with subsequent research for conditions like autoimmune diseases. 🤞🏾